semaglutide lowers risk of heart issues regardless of weight loss GLP-1 drugs' health benefits not solely from loss: study Does Ozempic Help Your Heart?

TB-500 stimulates the migration of endothelial cells, keratinocytes, and cardiac progenitor cells

Modeling the potential impact of incretin-based therapies as weight-loss and diabetes treatments on population morbidity and mortality trends The RGA model Quantifying potential impacts of incretin-based therapies on mortality and morbidity outcomes is difficult, given the many uncertainties at play

Its a popular drug, but its not without side effects

Some patients demonstrate primary non-response, where even optimal dosing produces minimal clinical benefit

The legal landscape remains fluid, and staying informed about regulatory changes is critical for anyone relying on compounded products for their GLP-1 therapy